Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
30.24
+2.15 (7.65%)
At close: Jul 27, 2026, 4:00 PM EDT
29.87
-0.37 (-1.22%)
Pre-market: Jul 28, 2026, 6:36 AM EDT
Hims & Hers Health Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Hims & Hers Health stock has a consensus rating of "Hold" and an average price target of $29.77. The average 1-year stock price forecast is 1.55% lower than the current stock price, while the lowest is $21 (-30.56%) and the highest is $40 (+32.28%).
Price Target: $29.77 (-1.55%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Hims & Hers Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 3 | 3 | 2 | 2 |
| Hold | 10 | 12 | 12 | 12 | 11 | 11 |
| Sell | 1 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 16 | 16 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $40 | Buy | Maintains | $40 | +32.28% | Jul 24, 2026 |
| Truist Financial | Truist Financial | Hold Reiterates $23 → $27 | Hold | Reiterates | $23 → $27 | -10.71% | Jul 24, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $37 | Hold | Maintains | $37 | +22.35% | Jul 24, 2026 |
| Barclays | Barclays | Buy Maintains $39 | Buy | Maintains | $39 | +28.97% | Jul 24, 2026 |
| Citi | Citi | Hold Maintains $28 → $35 | Hold | Maintains | $28 → $35 | +15.74% | Jul 23, 2026 |
Financial Forecast
Revenue This Year
3.05B
from 2.35B
Increased by 29.84%
Revenue Next Year
4.16B
from 3.05B
Increased by 36.41%
EPS This Year
0.68
from 1.10
Decreased by -38.10%
EPS Next Year
1.30
from 0.68
Increased by 91.33%
EPS and Forward PE are based on non-GAAP adjusted numbers.